Ronen Samuel - 18 Mar 2026 Form 3 Insider Report for Kornit Digital Ltd. (KRNT)

Role
Chief Executive Officer, Director
Signature
/s/ Assaf Zipori, attorney-in-fact
Issuer symbol
KRNT
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 12:10:56 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Samuel Ronen Chief Executive Officer, Director C/O KORNIT DIGITAL LTD., 12 HA'AMAL ST., ROSH-HA'AYIN, ISRAEL /s/ Assaf Zipori, attorney-in-fact 18 Mar 2026 0001990890

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KRNT Ordinary shares 101,494 18 Mar 2026 Direct
holding KRNT Ordinary shares 11,788 18 Mar 2026 Direct F1
holding KRNT Ordinary shares 13,095 18 Mar 2026 Direct F2
holding KRNT Ordinary shares 21,724 18 Mar 2026 Direct F3
holding KRNT Ordinary shares 39,967 18 Mar 2026 Direct F4
holding KRNT Ordinary shares 164,582 18 Mar 2026 Direct F5
holding KRNT Ordinary shares 32,302 18 Mar 2026 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KRNT Options (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 37,500 $28.15 Direct F7
holding KRNT Options (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 10,350 $57.79 Direct F8
holding KRNT Options (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 5,005 $122.19 Direct F9
holding KRNT Options (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 23,775 $35.51 Direct F10
holding KRNT Options (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 23,158 $22.02 Direct F11
holding KRNT Options (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 48,525 $23.00 Direct F12
holding KRNT Options (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 65,036 $16.48 Direct F13
holding KRNT Options (right to buy ordinary shares) 18 Mar 2026 Ordinary shares 68,009 $15.19 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on August 11, 2022 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 11, 2026).
F2 The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on December 29, 2022 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (December 29, 2026).
F3 The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2027).
F4 The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2028).
F5 The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs will vest and settle for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs will vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2029).
F6 The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs will vest and settle for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs will vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2029).
F7 All options to purchase ordinary shares reported in this row fully vested and became exercisable prior to the date of this report.
F8 All options to purchase ordinary shares reported in this row fully vested and became exercisable prior to the date of this report.
F9 All options to purchase ordinary shares reported in this row fully vested and became exercisable prior to the date of this report.
F10 The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 11, 2022 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 11, 2026).
F11 The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on December 29, 2022 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (December 29, 2026).
F12 The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 12, 2023 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 12, 2027).
F13 The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 12, 2024 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 12, 2028).
F14 The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 12, 2025 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options will vest upon the one-year anniversary of the grant date, and an additional 6.25% of the options will vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 12, 2029).

Remarks:

Exhibit 24.1 - Power of Attorney